Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway

Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization

(2014) Kunkun Han et al.   Journal of Hematology & Oncology

Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application

(2014) Xun Yuan et al.   Journal of Hematology & Oncology

Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma

(2014) Ye Song et al.   Molecular Cancer

Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy

(2014) L Xiao et al.   ONCOGENE

Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma

(2014) H Wang et al.   Cell Death & Disease

Vaccination With ENO1 DNA Prolongs Survival of Genetically Engineered Mice With Pancreatic Cancer

(2013) Paola Cappello et al.   GASTROENTEROLOGY

Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics

(2013) Akintunde Akinleye et al.   Journal of Hematology & Oncology

Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes

(2013) Roberto Gomez-Casal et al.   Molecular Cancer

Reduced CTGF Expression Promotes Cell Growth, Migration, and Invasion in Nasopharyngeal Carcinoma

(2013) Yan Zhen et al.   PLoS One

Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma

(2013) Yan Zhen et al.   Cell Death & Disease

Proteomic analysis of differential protein expression by brain metastases of gynecological malignancies

(2013) Ayako Yoshida et al.   Human Cell

Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma

(2012) Zhen Liu et al.   BMC CANCER

RETRACTED: Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma

(2012) Ponlapat Yonglitthipagon et al.   CLINICAL BIOCHEMISTRY

α-Enolase, a Multifunctional Protein: Its Role on Pathophysiological Situations

(2012) Àngels Díaz-Ramos et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells

(2012) Xue Dong et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

(2012) Julian R. Molina et al.   MAYO CLINIC PROCEEDINGS

EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer

(2012) Sandeep Singh et al.   Molecular Cancer

Estrogen Promotes Prostate Cancer Cell Migration via Paracrine Release of ENO1 from Stromal Cells

(2012) Lin Yu et al.   MOLECULAR ENDOCRINOLOGY

Differential Proteomic Analysis of Noncardia Gastric Cancer from Individuals of Northern Brazil

(2012) Mariana Ferreira Leal et al.   PLoS One

Proteomic features of potential tumor suppressor NESG1 in nasopharyngeal carcinoma

(2012) Zhen Liu et al.   PROTEOMICS

Overexpression of α-enolase correlates with poor survival in canine mammary carcinoma

(2011) Pei-Yi Chu et al.   BMC Veterinary Research

α-enolase: a promising therapeutic and diagnostic tumor target

(2011) Michela Capello et al.   FEBS Journal

Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer

(2011) Diego Serrano et al.   Molecular Cancer

Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

(2011) Z. J. Reitman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Proteomics characterization of gastrokine 1-induced growth inhibition of gastric cancer cells

(2011) Guang-Rong Yan et al.   PROTEOMICS

Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101 and miR-98

(2011) N M Alajez et al.   Cell Death & Disease

Diagnostic Detection of Human Lung Cancer-Associated Antigen Using a Gold Nanoparticle-Based Electrochemical Immunosensor

(2010) Ja-an Annie Ho et al.   ANALYTICAL CHEMISTRY

ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction

(2010) Sen-Tien Tsai et al.   EUROPEAN JOURNAL OF CANCER

MBP-1 is efficiently encoded by an alternative transcript of the ENO1 gene but post-translationally regulated by proteasome-dependent protein turnover

(2010) Jrhau Lung et al.   FEBS Journal

Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma

(2010) Bogusz Trojanowicz et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma

(2010) Luxia Tu et al.   Molecular Cancer

Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy

(2010) Yunching Chen et al.   MOLECULAR THERAPY

Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung

(2009) M. Wygrecka et al.   BLOOD